Neuromonitoring of recurrent laryngeal nerves in thyroid cancer in combination with autoimmune thyreodit

Ryabchenko E.V., Durleshter V.M.

For the first time, the results of neuromonitoring recurrent laryngeal nerves (NRLN) in the treatment of the oncological process in the thyroid gland (thyroid gland) in combination with autoimmune thyroiditis (AIT) are presented. A significant frequency of laryngeal paresis during surgical intervention in AIT can be explained by inflammatory periprocess. This is a non-specific process that is localized in tissues located near the gland, which makes it difficult to isolate and visualize the recurrent laryngeal nerve (RLN) and parathyroid glands during surgery on the autoimmune affected organ. The paper presents the experience of using NRLN in this pathology, as well as the possible prevention of bilateral paresis of the laryngeal muscles.

Aim. To evaluate the results of the use of neuromonitoring of the function of the nerves of the larynx in thyroid cancer in combination with AIT, as well as to consider the alleged risks of complications after surgery on an autoimmun organ.

Material and methods. In the Department of Endocrine Surgery, from 01.10.20 to 01.07.21. 120 surgical interventions for thyroid cancer in combination with AIT were performed: with papillary cancer — 100 patients, follicular cancer — 12 patients, medullary — 8 patients. All interventions were carried out using neuromonitoring of the RLN function.

1. Konturek A1, Barczyński M, Wierzchowski W, Stopa M, Nowak W. Coexistence of papillary thyroid cancer with Hashimoto thyroiditis. Langenbeck’s Arch. Surg. 2013; 398(3): 389-394.

2. Silva de Morais N, Stuart J, Guan H, Wang Z, Cibas ES, Frates MC, Benson CB, Cho NL, Nehs MA, Alexander CA, et al. The impact of Hashimoto thyroiditis on thyroid nodule cytology and risk of thyroid Cancer. J Endocr Soc. 2019; 3: 791-800.

3. Kaprin AD, Starinsky VV, Petrova GV. The state of oncological care for the population of Russia in 2016. M.: P.A. Herzen MNIOI — branch of the Federal State Financial University “NIRRC” of the Ministry of Health of Russia, 2017. (In Russ).

4. Sinclair IS. The risk to the recurrent laryngeal nerves in thyroid and parathyroid surgery. J R Coll Surg Edinb. 1994; 39(4): 253-257.

5. Vasilenko YuS, Romanenko SG. Clinical and functional examination of patients with unilateral laryngeal paralysis. Bulletin of Otorhinolaryngology. 2000; 5: 50-53. (In Russ).

6. Sancho JJ, Pascual-Damieta M, Pereira JA, et al. Risk factors for transient vocal cord palsy after thyroidectomy. Br J Surg. 2008; 95(8): 961-967. doi: 10.1002/bjs.6173.

7. Caragacianu D, Kamani D, Randolph GW. Intraoperative monitoring: normative range associated with normal postoperative glottic function. Laryngoscope. 2013; 123(12): 3026-3031. doi: 10.1002/lary.24195.

8. Vetshev PS, Yankin PL, Zhivotov VA. Ultrasound examination of the larynx in the diagnosis of mobility disorders of the vocal folds. Endocrine surgery. 2016; 10(3): 5-14. (In Russ).

9. Chiang FY, Lu IC, Kuo WR, et al. The mechanism of recurrent laryngeal nerve injury during thyroid surgery: the application of intraoperative neuromonitoring. Surgery. 2008; 143: 743-749.

10. Randolph GW, Dralle H. International Nerve Monitoring Study Group. Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: international standards guideline statemen. Laryngoscope. 2011; 121(1): 1-16.

11. Duclos A, Lifante JC, Ducarroz S, et al. Influence of intraoperative neuromonitoring on surgeons’ technique during thyroidectomy. World J. Surg. 2011; 35: 773-778.

12. Melin M, Schwarz K, Lammers BJ, Goretzki PE. IONMguided goiter surgery leading to two-stage thyroidectomy — indication and results. Langenbecks Arch Surg. 2013; 398: 411–418.

13. Schneider R, Sekulla C, Machens A, et al. Postoperative vocal fold palsy in patients undergoing thyroid surgery with continuous or intermittent nerve monitoring. Br. J. Surg. 2015; 102: 1380-1387. doi:10.1002/ bjs.9889.